Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Mother-to-child Transmission in the Third Trimester: a Multicenter, Prospective Study

NCT04237376 is registered in ClinicalTrials.gov with New Discovery LLC as lead sponsor.

NCT NCT04237376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04237376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Mother-to-child Transmission in the Third Trimester: a Multicenter, Prospective Study
Lead sponsor
New Discovery LLC
Phase
Observational
Overall status
Unknown status
Start date
April 9, 2019
Completion date
September 30, 2020
Enrollment
600 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic, pregnancy related